Bristol-Myers Squibb Company (BMY)

BMY Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	7,271	7,055	-8,933	8,040	6,345	7,014
Depreciation & Amortization	3,593	4,011	9,600	9,760	10,276	10,686
Stock-Based Compensation	555	553	507	518	457	583
Other Adjustments	3,132	2,992	13,206	-2,544	-1,783	-815
Change in Receivables	1,377	-295	264	-995	-663	-1,054
Changes in Inventories	-1	-184	-486	-751	-69	13
Changes in Accounts Payable	492	-2	184	198	109	245
Changes in Income Taxes Payable	129	-4	-1,260	-603	-1,423	-1,063
Changes in Other Operating Activities	-4,056	30	2,108	237	-183	598
Operating Cash Flow	13,306	14,156	15,190	13,860	13,066	16,207
Operating Cash Flow Growth	-7.02%	-6.81%	9.60%	6.08%	-19.38%	15.34%
Capital Expenditures	-1,398	-1,311	-1,248	-1,209	-1,118	-973
Purchases of Investments	-2,145	-2,000	-769	-1,774	-3,592	-5,478
Proceeds from Sale of Investments	2,570	2,052	1,387	948	6,629	6,775
Payments for Business Acquisitions	-3,931	-3,944	-21,821	-1,169	-4,286	-1,610
Proceeds from Business Divestments	1,140	1,071	1,099	909	1,305	748
Investing Cash Flow	-3,764	-4,132	-21,352	-2,295	-1,062	-538
Short-Term Debt Issued	-	-	2,987	-	-	-
Short-Term Debt Repaid	-	-	-3,000	-	-	-
Net Short-Term Debt Issued (Repaid)	-	-	-13	-	-	-
Long-Term Debt Issued	5,740	5,740	12,883	4,455	5,926	-
Long-Term Debt Repaid	-11,440	-10,940	-2,873	-3,879	-11,431	-6,022
Net Long-Term Debt Issued (Repaid)	-5,700	-5,200	10,010	576	-5,505	-6,022
Issuance of Common Stock	-123	-128	-106	27	984	641
Repurchase of Common Stock	-	-	-	-5,155	-8,001	-6,287
Net Common Stock Issued (Repurchased)	-123	-128	-106	-5,128	-7,017	-5,646
Common Dividends Paid	-5,070	-5,045	-4,863	-4,744	-4,634	-4,396
Other Financing Activities	-22	25	99	-120	194	-160
Financing Cash Flow	-10,915	-10,348	5,127	-9,416	-16,962	-16,224
Effect of Exchange Rate Changes on Cash and Cash Equivalents	81	195	-137	45	-33	-102
Net Cash Flow	-1,292	-129	-1,172	2,194	-4,991	-657
Free Cash Flow	11,908	12,845	13,942	12,651	11,948	15,234
Free Cash Flow Growth	-7.29%	-7.87%	10.21%	5.88%	-21.57%	14.55%
FCF Margin	24.56%	26.65%	28.87%	28.11%	25.88%	32.84%
Free Cash Flow Per Share	5.83	6.30	6.88	6.09	5.57	6.79
Levered Free Cash Flow	329.5	4,395	9,962	16,248	8,432	10,498
Unlevered Free Cash Flow	6,309	10,106	917.04	14,569	14,411	15,896

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q